Intensive insulin treatment in diabetic children

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 14, Issue 5, 2001, Pages 292-304

  Ludvigsson, J ^a   Bolli, G B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Adolescents; Children; Hypoglycaemia; Intensive insulin therapy; Life quality; Metabolic control; Self control

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN;

ADOLESCENT; ADULT; BLOOD GLUCOSE MONITORING; CHILD; COMPLICATION; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DISEASE COURSE; DRUG ABSORPTION; DRUG FORMULATION; DRUG MECHANISM; DRUG SYNTHESIS; EXERCISE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; LIFESTYLE; LONG TERM CARE; MAJOR CLINICAL STUDY; ONSET AGE; PARENT; PATIENT EDUCATION; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SLEEP; TREATMENT INDICATION; TREATMENT PLANNING;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS; INSULIN; INSULIN INFUSION SYSTEMS; PATIENT EDUCATION;

EID: 0035664269     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. The quest for normoglycemia an historical perspective
2. Diabetes Mellitus
3. Diabetes mellitus in childhood and adolescence
4. Adherence to insulin treatment, glycaemic control and ketoacidosis in insulin-dependent diabetes mellitus
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
6. Effect of intensive diabetes treatment on the development and progression of long term complications in adolescents with insulin dependent diabetes mellitus
7. Comparison of metabolic control in a cross-sectional study of 2873 children and adolescents with IDDM from 18 countries
8. Effects of enhanced conventional therapy on metabolic control in children with insulin-dependent diabetes mellitus
9. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study
10. Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients - An update of the Steno studies
11. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
12. Hypoglycemia in the treated diabetic patient. A risk of intensive insulin therapy
13. Hypoglycemia during intensified insulin therapy of young children
14. Hypoglycemia during intensified insulin therapy of children and adolescents
15. Effect of twice daily subcutaneous administration of a long-acting somatostatin analog on 24-hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus
16. Prevention of nocturnal hypoglycemia in intensive therapy of IDDM
17. The pharmacokinetic basis of insulin therapy in diabetes mellitus
18. How to ameliorate the problem of hypoglycemia in intensive as well as non-intensive treatment of Type 1 diabetes mellitus
19. 1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime
20. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus
21. From physiology of glucose counterregulation to prevention of hypoglycaemia in Type 1 diabetes mellitus
22. Intensive treatment maintains normal glucagon response to hypoglycemia in short-term IDDM
23. Effects of intensive therapy on residual beta-cell function in patients with Type 1 diabetes in the diabetes control and complication trial. A randomized controlled trial
24. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children
25. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM
26. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus
27. Hypoglycemia: The limiting factor in the management of IDDM
28. Meticulous prevention of hypoglycemia (near-)normalizes magnitude and glycemic thresholds of neuroendocrine responses to, symptoms of, and with IDDM of short duration
29. Role of cortisol in the pathogenesis of deficient counter-regulation after antecedent hypoglycemia in normal humans
30. Effect of recent, antecedent hypoglycemia and responses of cortisol per se, on responses to subsequent hypoglycemia in humans
31. Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes
32. Nocturnal hypoglycaemia in IDDM patients younger than 18 years
33. Hypoglycemia unawareness
34. Association between diabetes, severe hypoglycemia and electroencephalographic abnormalities
35. Longitudinal relationship of asymtomatic hypoglycemia to cognitive function in IDDM
36. Shift of glycaemic thresholds for cognitive function in hypoglycaemia unawareness in humans
37. Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia)
38. A Prospective Study of Symptomatic Hypoglycaemia in Childhood Diabetes
39. Severe hypoglycaemia in youth with insulin-dependent diabetes mellitus: Frequency and causative factors
40. Hypoglycaemia in the diabetic child
41. Severe hypoglycemia in IDDM Children
42. Symptomatic hypoglycaemia in childhood diabetes. A population-based questionnaire study
43. Increasing incidence of hypoglycemic coma in children with IDDM
44. Hypoglykämien bei Kindern mit Diabetes unter humanem oder porcinem Insulin
45. Glucose counterregulation in preschool-age diabetic children with recurrent hypoglycemia during conventional treatment
46. Severe hypoglycaemia in children with insulin-dependent diabetes mellitus: Frequency and predisposing factors
47. Severe hypoglycemia in children and adolescents with IDDM: Frequency and associated factors
48. Severe hypoglycemia in children with IDDM: A prospective population study 1992-1994
49. Metabolic control in juvenile diabetes mellitus
50. Declining incidence of nephropathy in insulin-dependent diabetes mellitus
51. Glycemic control and prognosis in Type 1 diabetic patients with microalbuminuria
52. Adverse events in intensively treated children and adolescents with type 1 diabetes
53. 1c, risk for severe and mild hypoglycaemia, status of counterregulation and unawareness of hypoglycaemia
54. Intensified insulin therapy and the risk for severe hypoglycaemia
55. Implementation of treatment protocols in the Diabetes Control and Complications Trial
56. Hypoglycemia in the Diabetes Control and Complications Trial
57. Beta cell function in children with diabetes
58. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies
59. Insulin analogues and their potential in the management of diabetes mellitus
60. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age; a Belgian experience
61. Nocturnal blood glucose control in Type 1 diabetes mellitus
62. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes
63. Insulin pharmacokinetics
64. Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins
65. Long-term intensive treatment of Type 1 diabetes with the short-acting insulin analogue lispro in variable combination with NPH insulin at mealtime
66. Pharmacokinetics and pharmacodynamics of the long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin injected subcutaneously and continuous subcutaneous infusion of insulin lispro
67. Insulin glargine
68. Nocturnal glucose and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen
69. Effects of the short-acting insulin analog [LYS(B28),PRO(B29)] on post-prandial blood glucose control in IDDM
70. Use of the short-acting insulin analogue lispro in intensive treatment of IDDM: Importance of appropriate replacement of basal insulin and time-interval injection-meal
71. Multiple daily self-glucose monitoring: Its essential role in long-term glucose control in insulin-dependent patients treated with pump and multiple subcutaneous injections
72. Insulininfusionspump - Alternativ till konventionell insulinbehandling vid barn och ungdomsdiabetes
73. Insulin infusion pump treatment of Type 1 diabetes
74. Insulin pump treatment in insulin-dependent diabetes mellitus. Children, adolescents and young adults
75. Predicting nocturnal hypoglycemia in patients with type 1 diabetes treated with continuous insulin infusion
76. Continuous subcutaneous insulin infusion in children
77. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: Two-year follow-up of a randomized, prospective trial
78. Insulinpump - Ett realistiskt alternativ i behandlingen av diabetes hos barn och ungdomar
79. Reduction in severe hypoglycaemia with long-term continuous insulin infusion in type 1 diabetes
80. Insulin pump therapy in Type 1 pediatric patients: Now and into the year 2000